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Background: Quality of life has been found to be a significant predictor of survival in
lung transplantation candidates. The aim of this study was to investigate associations
between underweight, dietary support and well-being.
Methods: A self-administered questionnaire for perceived well-being was adminis-
tered to underweight (n ¼ 42) and normal-weight (n ¼ 29) candidates for lung
transplantation before and after dietary intervention in which the underweight
patients received dietary support for weight gain.
Results: Underweight compared with normal-weight, independent of lung function,
was associated with low well-being in several of the measured dimensions.
Improvements were observed after dietary intervention compared with baseline in
the underweight patients, for scores in the dimension of tiredness 29.2 (4.2) vs. 26.2
(6.0), Po0:01; general satisfaction 4.7 (1.5) vs. 4.0 (1.4), P ¼ 0:01; social life 16.7 (3.9)
vs. 15.0 (4.4), P ¼ 0:02) (mean (SD) before and after dietary intervention respectively),
but not in the normal-weight patients. The underweight patients achieved the goal for
energy intake and protein intake and experienced a significant weight gain. Regression
analyses showed that none of the well-being improvements was associated with weight
gain or change in body composition. However, an association between less tiredness and
an increase in protein intake was indicated (b ¼ 0:305, P ¼ 0:055).
Conclusion: Underweight compared with normal-weight was associated with more
impaired quality of life in candidates for lung transplantation and some benefit from
dietary support in terms of well-being was indicated.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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The clinically adverse influence of weight loss in
patients with chronic obstructive pulmonary dis-
ease (COPD) is indicated by a reduction in exercise
performance,1 an increase in morbidity, as evi-
denced by reports of increased frequency of
hospitalisation,2 and a reduction in survival.3
A few studies have reported on health-related
quality of life in COPD patients in relation to
nutritional depletion.4,5 Mostert et al.5 found
impaired health-related quality of life associated
with tissue depletion, independent of exercise
capacity and dyspnoea. Most data in the literature
on nutritional assessment and supplementation in
pulmonary disease relate to COPD patients. Quality
of life has increasingly been accepted as a
supplementary outcome measure.6 Weight gain
has been shown to improve the prognosis in
patients with COPD,7,8 but has scarcely been
studied in relation to quality of life.9
Because of the lack of organ donors, many
candidates for lung transplantation are waiting for
a long time for transplantation after acceptance and
several patients die while waiting for transplanta-
tion. Several studies have examined health-related
quality of life in candidates awaiting lung transplan-
tation. Studies have shown that quality of life
predicts survival in COPD patients10 and in candi-
dates for transplantation.11 It appears from the study
by Squier et al.11 that higher health-related function
may be associated with a better chance of survival
both before and after lung transplantation. No
attention has been paid to improvement of nutri-
tional status and its relationship to quality of life in
patients awaiting lung transplantation.
The purpose of this study was thus (1) to examine
whether underweight was associated with impaired
quality of life in a group of underweight and
normal-weight candidates for lung transplantation
and (2) to study well-being after dietary support for
weight gain in the underweight patients.Material and methods
Patients and study design
In this cross-sectional, prospective intervention study,
we studied 71 underweight (n ¼ 42) and normal-
weight patients (n ¼ 29), who were consecutively
referred to the Department of Thoracic Medicine and
assessed for lung transplantation between August
1993 and August 1998. In underweight and normal-
weight patients, respectively, the majority had COPDantitrypsin deficiency without liver affection (n ¼ 5
and n ¼ 1)), while other diagnoses (OTHERS) were
fibrosing alveolitis (n ¼ 4 and n ¼ 7), sarcoidosis
(n ¼ 2 and n ¼ 4), bronchiectasis (n ¼ 4 and n ¼ 0)
and lymphangioleiomyelomatosis (n ¼ 3 and n ¼ 1).
Patients with cystic fibrosis, pulmonary hypertension
or overweight patients (body mass index (BMI) over
25 kg/m2) were excluded.
The patients participated in a dietary interven-
tion study for weight gain in the underweight
patients and weight maintenance in the normal-
weight ones.12 Anthropometric measurements and
lung function tests were performed after arrival at
the hospital, when entering the study (first visit),
and after intervention on the second visit to the
hospital. The patients were contacted by telephone
in their homes 3–4 weeks prior to their first and
second admission to hospital. After obtaining the
patient’s informed consent, questionnaires for
quality of life, a scale and a booklet for recording
food were mailed to the patient. The question-
naires were self-administered. The patients re-
corded their food intake 3–4 weeks prior to their
first admission to hospital. Food records were also
kept during hospitalisation and at the end of the
intervention period, 3–4 weeks prior to the second
visit to the hospital.
The dietary intervention study consisted of in-
patient dietary support,13 followed by outpatient
dietary intervention.12 Following arrival at the
hospital, the underweight patients were randomly
allocated to two groups (Group A and Group B).
Group A received intensified dietary support; while
they were in hospital, they were offered an energy-
rich diet with the addition of oral ready-made liquid
nutritional supplements if they wanted them. Groups
B and C (normal-weight patients) received the
normal diet and regular support in hospital. Both
groups A and B received outpatient dietary counsel-
ling, including meal planning and individual dietary
suggestions. As outpatients, Group A received oral
liquid nutritional supplements free of charge, while
Group B received no supplements free of charge.
After the patients had been assessed for lung
transplantation, they were put on a waiting list and
re-admitted to hospital every 4–5 months for
medical controls. All measurements were per-
formed before transplantation. The regional ethics
committee approved the study.Anthropometric measurements
Normal-weight patients had a BMI (the ratio of body
weight (kg) to height squared (m2)) of between 19
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Underweight dietary support on well-being 1241and 25 and a weight loss equal to or less than 10%.
The criteria for underweight were BMI below 19 kg/
m2 or BMI of between 19 and 25 kg/m2 with a
weight loss of more than 10% from the usual
weight. This was because a weight loss of more
than 10% in the terminal stages of COPD has shown
to be associated with reduced survival.14 In 1993,
when the study started, we also considered general
guidelines. The Norwegian guideline for under-
weight has been under or equal to 15% of IBW.15 We
chose a BMI of 19 kg/m2 as the low cut-off point for
underweight. Patients were asked for weight
changes during the last 3 months and the last year
before entering the study. Fat mass (FM) was
determined by four skinfold measurements (bicipi-
tal, tricipital, subscapular and suprailiac) using the
Durnin tables.16 The fat-free mass (FFM) was
assessed by subtracting the FM from the body
weight. The fat-mass index and FFM index was
computed by dividing FM and FFM, respectively, by
the height squared.
Lung function
An automated pulmonary function unit (Gould
2400, Sensormedics, Bilthoven, the Netherlands)
was used to measure spirometry variables; forced
expiratory volume in 1 s (FEV1). The reference
values were those recommended by the European
Respiratory Society.17
Quality of life questionnaires
Quality of life and subjective well-being was
measured by items used and evaluated in general
population surveys in Norway18,19 and in clinical
research.20–22 The questionnaire evaluates several
indexes:
Index (1): Time spent in bed over the last 14
days.
Index (2): Dimensions of tiredness or full of
energy (six items each with 6step bipolar): (2a)
At the present time, do you mostly feel strong
and fit, or tired and worn out and, during the
course of the last 14 days, (2b) Did you feel worn
out, drained or exhausted, (2c) Did you feel that
you had plenty of energy, (2d) Did you feel that
you were full of ‘‘pep’’, (2e) Did you feel that
you had enough initiative to do what you wanted
to do, (2f) Did you feel tired.
Index (3): Would you say that you are usually
cheerful or dejected (7step bipolar).
Index (4): Do you generally feel calm and good
about yourself (4step bipolar).Index (5): Considering how you feel these days,
are you generally satisfied with your life or are
you generally dissatisfied (7step bipolar).
Index (6): Cantril ladder for the best possible life
or the worst possible life (10-rank).
Index (7): Present limitations in social and family
activities (two items each with 15-cm linear
scale), with high scores indicating poorer well-
being.
Index (8): Present limitations in usual daily
activities (10 tick-off items), and
Index (9): How often taken tranquillisers/seda-
tives or sleeping medication over the course of
the last month? (4step frequency).
Indexes 3, 4, 5 and 9 have been validated in a
Norwegian county survey, Nord-Trondelag Health
Survey19,21 while index 2 has been adapted from
‘‘vitality’’ dimension of the Short Form 36 (SF-
36).18 Index 6 has been used internationally, as well
as with Norwegian patients.20
To characterise the patients, they were also
asked whether they lived alone, the number of
hospital stays last year and they were also asked:
Do you have difficulty buying food? (yes/no), Do you
have difficulty cooking? (yes/no), Who does the
cooking? (patient/others/get ready-made) and
Does eating make you tired? (yes/no).Statistical analysis
The data were analysed using the SPSS program
(SPSS for Windows, Release 9.0.0, SPSS Inc.,
Chicago, IL, 1998). The results are reported as n
(%), mean (SD) and frequencies. Statistically sig-
nificant differences were tested for dimensions of
quality of life, weight change and FFM change. An
independent-samples t-test or a Pearson w2-test
was used to compare groups. Changes in quality of
life were assessed by paired t-tests within groups.
Internal consistency reliability for the multi-item
indices was assessed by Cronbach’s coefficient of
alpha. Scales with an alpha above 0.70 are
generally regarded as homogeneous and taken as
evidence of good reliability for a scale. To ensure
strict comparability between our multi-item index
tiredness before and after intervention, factor
(principal components) analysis was performed to
evaluate factor score coefficients (i.e. the weights
attached to each individual item). Pearson’s corre-
lation coefficient was used to estimate the associa-
tion between changes in tiredness and changes in
energy intake or protein intake. Multiple linear
regression analyses were performed to test
whether improvements in well-being measures
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change, change in FFM or protein intake, control-
ling for baseline values. P-values less than 0.05
were regarded as significant using a two-tailed test.Results
Patient characteristics at entry for the underweight
and normal-weight patients are shown in Table 1.
Only a minority of the underweight patients had a
recent significant weight loss (X5%). More under-
weight patients said that they had difficulties with
cooking and were more tired by eating. The
underweight patients had more stays in hospital
during the last year (Table 1) and had spent more
days in bed during the course of the last 14 days
(Table 2). At baseline, the underweight patients
also had more impaired quality of life than theTable 1 Patient characteristics at baseline.
Variables Un
N
Age (years, range)
Male/female 20
FEV1 (% predicted)

Steroid therapy (n, %)
Steroid therapy (mg)
Weight (kg) 50
Weight change last 3 months (n, %) y
X5% weight loss
o5% weight loss
45% weight gain
Weight change last year (n, %)
X5% weight loss
o5% weight loss
45% weight gain
Body mass index (kg/m2) 17
Fat free mass index (kg/m2) 14
Fat mass index (kg/m2) 3
Energy intake/REE predicted (%) 1
Protein intake (g)
Lived alone (n, %)
Number of hospital stays last year (n) 3
Difficulties cooking (n, %)
Difficulties buying foods (n, %)
Who cooks (n, %) y
Patient
Others
Get ready-made food
Tired from eating (n, %)
FEV1 ¼ forced expiratory volume in 1 s; REE ¼ resting energy exp
Mean (SD).
yOne value missing.normal-weight patients for several of the other
measured scores: index 4 (generally feel calm and
good about themselves); index 6 (for the dimension
of the best possible life or the worst possible life);
index 7 (for dimensions of present limitations in
social and family activities) and index 9 (more
often had taken tranquillisers/sedatives or sleeping
medication over the course of the last month)
(Table 2). The differences between underweight
and normal-weight patients remained the same
after controlling for FEV1.
The mean intervention time was 21 weeks (range
13–44) in the underweight patients and 18 weeks
(range 11–26) in the normal-weight ones. Thirty-
one underweight patients and 23 normal-weight
ones completed the whole intervention. Those who
did not complete either died (n ¼ 8 and n ¼ 2,
underweight and normal-weight, respectively) or
were transplanted (n ¼ 3 and n ¼ 4). Three under-
weight patients were transplanted just before thederweight Normal-weight
¼ 42 N ¼ 29
47 (25–60) 52 (26–60)
/21 12/17
23 (13) 26 (13)
20 (48%) 23 (79%)
8 (12) 7 (6)
.5 (7.5) 64.5 (8.3)
6 (15%) 4 (14%)
29 (71%) 19 (66%)
6 (15%) 6 (21%)
20 (48%) 7 (24%)
17 (41%) 10 (35%)
5 (12%) 6 (41%)
.3 (1.8) 22.2 (1.5)
.4 (1.4)( 15.7 (1.5)
.1 (1.5)( 6.5 (1.3)
50 (37)( 130 (33)
67 (18)( 75 (23)
9 (22%)y 4 (14%)
.1 (2.3)y 2.0 (1.7) (P ¼ 0:035)
30 (75%)y 12 (43%) (P ¼ 0:007)
6 (15%)y 3 (10%)
15 (37%) 15 (57%)
22 (54%) 13 (45%)
4 (10%) 1 (3%)
29 (71%)y 12 (41%) (P ¼ 0:013)
enditure predicted by Harris and Benedict equation.
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Table 2 Scores in dimensions of quality of life before and after dietary intervention.
Variables Underweight Normal-weight Py
Baseline After P Baseline After P Underweight
compared
with normal-
weight at
baseline
Index number: N ¼ 40 N ¼ 30 N ¼ 29 N ¼ 22
1. In bed last 14 days
(days)
3.8 (5.3) 3.0 (5.1) 0.6 1.7 (2,8) 0.7 (1.4) 0.1 0.041
2. Tired (6 items) 29.2 (4.2) 26.2 (6.0) 0.007 27.6 (5.0) 26.4 (4.2) 0.2 0.15
6 ¼ never
36 ¼ all the time
3. Depressed/happy 3.4 (1.3) 3.8 (1.7) 0.3 3.3 (0.9) 3.2 (1.0) 0.3 0.6
1 ¼ extremely happy
7 ¼ extremely
depressed
4. Calm feeling 2.6 (0.9) 2.5 (1.0) 0.4 1.9 (0.8) 2.0 (0.9) 0.9 0.003
1 ¼ almost all the
time
4 ¼ never
5. Life satisfaction 4.7 (1.5) 4.0 (1.4) 0.012 4.1 (1.4) 4.0 (1.3) 0.1 0.1
1 ¼ extremely
satisfied
7 ¼ extr. dissatisfied
6. Worst/best life 8.0 (1.9) 7.2 (1.7) 0.012 7.1 (1.9) 6.9 (2.2) 0.8 0.045
1 ¼ best possible
10 ¼ worst possible
7. Limitation in family
and social life (2
items)
16.7 (3.9) 15.0 (4.4) 0.021 14.2 (4.7) 14.6 (3.7) 0.8 0.020
2 ¼ not at all
20 ¼ seriously
8. Practical housework 4.5 (2.0) 4.5 (2.0) 0.9 4.6 (1.8) 4.2 (2.1) 0.7 1.0
Less than usual of 10
activities
9. Medication last mo.
(tranquillisers, sleep)
0.007
Daily 18 (44%) 13 (43%) 5 (17%) 4 (18%)
Weekly, not daily 7 (17%) 3 (10%) 2 (7%) 2 (9%)
More rare 1 (2%) 5 (17%) 6 (21%) 4 (18%)
Never 15 (37%) 9 (30%) 16 (55%) 12 (55%)
By paired t-test.
yBy t-test/w2.
Underweight dietary support on well-being 1243planned end of the intervention period. Only
weight and dietary assessment were available for
the latter patients and are included in the data.
After intervention, both Groups A and B improved
their diet and gained weight with no differences
between the groups. After intervention, the energy
intake in all the underweight and normal-weight
patients was mean (SD) 192 (55) % of resting energy
expenditure predicted by Harris and Benedict
equation (REE predicted) and 132 (31) % and change
in protein intake, 11 (18) g and 6 (19) g,
respectively. The underweight patients increased
their weight significantly compared with the
normal-weight ones, 2.6 (2.9) kg and 0 (2.1) kg(P ¼ 0:001) and increased FFM, 0.7 (1.4) kg and
0.1 (1.5) kg (P ¼ 0:06), respectively. Only one
underweight patient lost more than 1 kg. For the
underweight patients who completed the interven-
tion, there was a significant improvement in four of
the nine dimensions of well-being measurements
repeated after dietary intervention, compared
with baseline (Table 2). Regression analyses showed
that none of the well-being improvements was
associated with weight gain. Increases in FFM were
associated with a reduction in tiredness (r ¼ 0:32,
P ¼ 0:027), but the significance did not remain
after controlling for baseline measurements.
Changes in energy intake were not associated with
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Figure 1 Correlation between changes in proteinintake
and changes in tiredness (index 2) assessed in all patients
(r ¼ 0:33, Po0:02).
L. Førli et al.1244changes in any of the well-being dimensions, but
increases in protein intake after intervention were
significantly correlated with a reduction in tired-
ness (r ¼ 0:33, P ¼ 0:019, Fig. 1) and displayed
borderline significance after controlling for base-
line measurements of protein intake and tiredness
(b ¼ 0:305, P ¼ 0:055).
With the patients in this study, Cronbach’s alpha
coefficient at both points in time for dimensions of
tiredness/full of energy and for dimensions of
limitations in social and family activities ranged
from 0.83 to 0.89. Because attempts with other
multi-item indices (indexes 3 and 5, indexes 5 and
6) produced a Cronbach’s alpha of o0.70, these
measures were reported separately.Discussion
Quality of life is important for candidates for lung
transplantation.23 Quality of well-being may be a
significant predictor of survival.11 Even in these
patients with severe limitations in functional
ability, there appears to be potential for improved
quality of life, as indicated in a pilot study that
examined the impact of exercise programmes.24
The results from our study showed that at baseline,
underweight was associated with more impaired
quality of life compared with the normal-weight
patients for several of the measured dimensions
and some improvements were observed after diet-
ary intervention in the underweight patients butnot in the normal-weight patients. Underweight
patients who achieved the goal for energy and
protein intake and experience a significant weight
gain,12 but the improvements in their well-being
were not associated with the weight gain or change
in body composition. In spite of this, achieving
positive energy balance and nitrogen retention
even without substantial weight gain could possibly
have contributed to the patients feeling less
impaired. Our data indicated an association be-
tween an increased intake of protein and a
reduction in tiredness. Protein supplementation
has been shown to be associated with a better
clinical outcome in elderly patients with hip
fractures,25 but few studies have examined the
question of dietary intake and quality of life.26 The
suggestion that improving nutrient intake per se
may play a valuable role was also suggested in
severely malnourished head and neck cancer
patients.27 In these patients, preoperative enteral
nutritional support improved quality of life, even
though their nutritional status was not improved.
As in the study by Squier et al.,11 our measures of
quality of life did not focus on disease-specific,
health-related quality of life. Even though general
well-being is influenced by the severity of disease, it
allows for an overall impact of illness and reflects the
patients’ perceived well-being. Both lung-specific
and general (SF-36) measures of quality of life have
been shown to be sensitive in candidates for lung
transplantation.28 One potential advantage of mea-
suring overall well-being, however, is that it includes
the impact of interventions and non-disease-specific
effects that may not be anticipated.29
At baseline, the most striking difference be-
tween underweight and normal-weight patients
was that the underweight patients, independent
of lung function, felt less calm compared with the
normal-weight patients. This is consistent with the
observation that the underweight patients used
more tranquillisers and sleeping medication and is
in agreement with the general view that psycholo-
gical distress is associated with malnutrition.30
Having a terminal lung disease and being given the
opportunity for treatment would most probably have
a substantial emotional impact on patients. There is
some uncertainty as to whether the improvements in
well-being were achieved by the nutritional support
or the extra medical attention the patients were
given. However, we have no evidence to support the
hypothesis that the feeling that something positive
had happened differed between the underweight
and normal-weight patients or that the medical
attention the patients received was perceived
differently by the underweight patients compared
with the normal-weight ones.
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experienced substantial limitations in their family
and social life and this was more marked in the case
of the underweight patients. In spite of practical
difficulties, several of the underweight patients
improved their food intake. Our questionnaire was
aimed at different dimensions of well-being, where
some items would also be related to dietary
behaviour, such as items in our index of tiredness
and family and social activities. A change in dietary
behaviour could potentially explain improvements
in quality of life, because cooking and eating are
important aspects of everyday life. Self-efficacy
and perceived behaviour control are important,
changeable determinants of dietary behaviour.31,32
If the patients are confident that they are able to
maintain a certain food intake, they will be more
motivated to try and their attempts will be more
persistent.31 Goal-directed behaviour is supposed
to be influenced by an evaluation of the belief in
the positive or negative consequences of the
behaviour.33 Short-term positive benefits of this
kind, such as being stronger before the transplan-
tation, could probably have influenced motivation
and shaped behaviour in our patients. Short-term
effects are usually more effective than long-term
effects34 and this is relevant in our patients with
end-stage pulmonary disease aiming for transplan-
tation.
Some of our patients who were struggling with
weight loss were satisfied if they could stop the
weight loss. Patient satisfaction with maintaining a
stable weight and avoiding further weight loss
could explain the lack of association between
weight gain and improvements in well-being. In a
previously published study of COPD patients,
improved quality of life was found after dietary
intervention and weight gain.9 However, in the
study by Creutzberg et al.,9 dietary intervention
was implemented in a rehabilitation programme
which also included physical training. In other
patient groups, in contrast to our results, the
restitution of body weight during nutritional
support was shown to be associated with signi-
ficant improvements in quality of life indices in
patients with chronic illness.35 In these patients,
the mean weight gain was 4.2 kg, which is higher
than in our patients. The higher weight gain could
have made a difference to the impact on quality
of life.
In conclusion, our results reveal that being
underweight is associated with more impaired
quality of life in candidates for lung transplanta-
tion. Benefits from dietary support on well-being,
which was not associated with weight gain, were
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